Dr. L. Rohit Reddy Consultant Medical Oncologist & Hemato Oncologist

Dr. L. Rohit Reddy

Dr. L. Rohit Reddy


Department: Medical Oncology
Designation: Consultant Medical Oncologist & Hemato Oncologist
Years Of Experience: 6
Location: Malakpet
Languages: Telugu, Hindi, English

Dr. L.Rohit Reddy is a leading Consultant Medical & Hemato Oncologist in Hyderabad. He educated from All India Institute of Medical Sciences, New Delhi, the top ranked medical institute in India. He completed his training under eminent professors and doctors at AIIMS, Delhi. Dr. Reddy previously trained in Internal Medicine from Kasturba Medical College, Manipal, a reputed medical institute in India

Dr. Reddy is an experienced Oncologist in diagnosis, planning, managing and executing treatments for all cancer subtypes.

Dr. Reddy makes listening to patients the number one priority in cancer treatment. He believes in helping cancer patients live productive life. He is a leader in cancer research. He offers hope at curing cancer.

Education Qualifications

Education Qualifications

  • 2019-2022: DM, Medical Oncology, All India Institute of Medical Sciences, New Delhi
  • 2015-2018: M.D, Internal Medicine, Kasturba Medical College, Manipal, Karnataka
  • 2008-2014: MBBS, Kamineni Institute of Medical Sciences, Narketpally, Telangana
  • 2019-01 - 2022-01: D.M: Medical Oncology, All India Institute of Medical Sciences, New Delhi
  • 2015-05 - 2018-05: M.D: Internal Medicine Kasturba Medical College - Manipal, Karnataka, India
  • 2013-04 - 2014-04: Compulsory Rotatory Internship: Medical Internee Gandhi Medical College - Secunderabad, India
Services offeredServices offered
  • Diagnosing cancer
  • Tumour board
  • Hemato oncology services
  • Hematopoietic Stem cell transplant and other cellular therapies
  • Chemotherapy, Targeted therapy
  • Immunotherapy
  • Cancer/Familial Screening services
  • Palliative counselling and treatment
  • Cancer genetic counselling
  • Holistic cancer care
Special Interest and ExpertiseSpecial Interest and Expertise
  • Treating benign and malignant hematologic disorders including offering hematopoietic stem cell transplant (including mismatch transplants)
  • Gynecologic (ovary, cervix, endometrium, GTN) and Genitourinary cancers (prostate, renal, bladder)
  • Gastrointestinalcancers (esophagus, stomach, colorectal, hepatopancreatobiliary cancers)
  • Thoracic oncology
  • Breast oncology
  • Sarcoma
  • Cancer screening
  • Preventive oncology
Professional MembershipProfessional Membership
  • Member of American Society of Clinical Oncology (ASCO)
  • Member of European Society of Medical Oncology (ESMO)
  • Member of European Society of Hematology (EHA)
  • Member of Society of hemato-oncology, USA (SOHO)
  • Trainee reviewer at Indian Journal of Medical and Paediatric Oncology (IJMPO)
  • Member of Indian Cooperative Oncology Network (ICON)
Research & PublicationsResearch & Publications
  • Reddy LR, Rasheed AA, Rastogi S. The evolving role of precision medicine in the management of advanced sarcomas – A mini review. Int J Mol Immuno Oncol, doi: 10.25259/IJMIO_6_2021
  • Sharma A, Biswas B, Reddy R, Thumbudorai R, Ganguly S, Dabkara D, Pramanik R, Kumar S, Sahoo RK, Sharma A, Kumar L. Seminomatous and non-seminomatous mediastinal germ cell tumors (MGCT): A real-world analysis from two tertiary care centers in India.
  • Verma S, Reddy R, Chandrashekhara SH, Shamim SA, Tripathy S, Rastogi S. Avapritinib in advanced gastrointestinal stromal tumor: case series and review of the literature from a tertiary care center in India. Future Science OA. 2020 Dec(0):FSO676.
  • Varma M, Reddy LR, Vidyasagar S, Holla A, Bhat NK. Risk factors for carbapenem resistant enterobacteriaceae in a teritiary hospital—A case control study. Indian Journal of Medical Specialities. 2018 Oct 1;9(4):178-83.
  • Weber SF, Bélard S, Rai S, Reddy R, Belurkar S, Saravu K. Immune thrombocytopenia secondary to tuberculosis: a case and review of literature. The International Journal of Tuberculosis and Lung Disease. 2017 Apr 1;21(4):466-70.
  • Bhat N, Vidyasagar S, Reddy R, Holla A. Ranitidine Induced Anaphylaxis. APIK Journal of Internal Medicine. 2016 Jul 1;4(3):36.
  • Thesis on “Prognostic factors and outcomes of relapsed Multiple Myeloma treated with antibody free regimes in an Indian scenario” at AIIMS, Delhi under guidance of Padma shri, Dr. Lalit Kumar
  • Research project on “Comparison of outcomes between biochemical relapse and clinical relapse when treated with IMid based triplet”
  • Risk factors and outcomes of Carbapenem resistant Enterobacteriaceae- A case control study, Thesis project at KMC, Manipal under guidance of Dr. Muralidhar Verma
  • Other Scientific Activities
    • Poster: MM-257: It’s the Response That Matters: Real-World Data of Multiple Myeloma Patients Treated without Upfront Stem Cell Transplant Lavu, Rohit Reddy et al. Clinical Lymphoma, Myeloma and Leukemia, Volume 21, S255- Presented at SOHO, Texas, 2021
    • Seminomatous and non-seminomatous mediastinal germ cell tumors (MGCT): A real-world analysis from two tertiary care centers in India. Aparna Sharma, Bivas Biswas, Rohit Reddy, Robin Thumbudorai, Sandip Ganguly, Deepak Dabkara, Raja Pramanik, Sunil Kumar, Ranjit Kumar Sahoo, Atul Sharma, Lalit Kumar, and Atul Batra Journal of Clinical Oncology 2021 39:15_suppl, e18726-e18726- e abstract ASCO 2021
    • Oral Presentation No. – O-6, titled “Indian experience with immunotherapy in sarcoma and GIST: A retrospective study" at IMSOS, India, 2021.
Awards and AchievementsAwards and Achievements
  • Won Best Poster award at CIDSCON, Nagpur, 2017
  • Won Best Poster award at APICON, Mumbai, 2017
  • Won 1st prize at Quiz competition at National level at APICON, Mumbai, 2017
  • Received scholarship grants for participating in various international meet such as Leukemia, Lymphoma and Myeloma conference, New York, October 2021 (Scholarship Award) (Virtual) European Society of Medical Oncology, 2021 (International Cancer Foundation grant). (Virtual) Society of hematologic oncology, Texas, USA, Sept 2021 (Young Investigator Program travel grant) European hematologic association, Annual meet, July 2021 (virtual) HOPE Asia, Sri Lanka, Asia, 2020
  • Recipient of YIP travel grant SOHO, Texas, USA, 2022
  • Recipient of travel grant for European hematology Association, Annual Conference, Vienna, Austria, 2022
  • Honors in Anatomy, Biochemistry, Pathology, Microbiology, Ophthalmology, ENT, Obstetrics & Gynecology

Reasons & Treatment For Lung Cancer


  • Yes Same as WhatsApp number
  • By clicking on Send, you accept to receive communication from Yashoda Hospitals on email, SMS, call and Whatsapp.
Select Department
Not Sure of the Specialty?

Choose your date & Slot

Change Date
Monday, OCTOBER 30
Enter Patient Details

Please Note: This session ends in 3:00 mins

Not Finding Your Preferred Slots?